Injectable soft tissue substitutes.
Historical and modern advances in the development of an injectable soft tissue substitute are reviewed. Nonbiologic alloplastic and biologic injectables are described. The authors' experiences, as well as those of others, employing presently available materials in terms of specific indications and special techniques are delineated. The search for a safe, effective, easy-to-use, and long-lasting soft tissue substitute continues.
Spira
M
M
Division of Plastic Surgery, Baylor College of Medicine, Houston, Texas.
Rosen
T
T
D000273:Adipose Tissue / Q000637:transplantation; D000614:Aminocaproates / Q000009:adverse effects / Q000592:standards; D003094:Collagen / Q000009:adverse effects / Q000592:standards; D005780:Gelatin / Q000009:adverse effects / Q000592:standards; D006801:Humans; D008768:Methylmethacrylates / Q000009:adverse effects / Q000592:standards; D019736:Prostheses and Implants / Q000009:adverse effects / Q000592:standards*; D012826:Silicone Elastomers / Q000009:adverse effects / Q000592:standards; D012828:Silicones / Q000009:adverse effects / Q000592:standards; D013518:Surgery, Plastic / Q000379:methods
D000614:Aminocaproates; C055487:Fibrel; D008768:Methylmethacrylates; D012826:Silicone Elastomers; D012828:Silicones; D005780:Gelatin; D003094:Collagen